NZ512496A - Ethanolate of azithromycin - Google Patents

Ethanolate of azithromycin

Info

Publication number
NZ512496A
NZ512496A NZ512496A NZ51249699A NZ512496A NZ 512496 A NZ512496 A NZ 512496A NZ 512496 A NZ512496 A NZ 512496A NZ 51249699 A NZ51249699 A NZ 51249699A NZ 512496 A NZ512496 A NZ 512496A
Authority
NZ
New Zealand
Prior art keywords
azithromycin
ethanolate
solution
forming
ethanol
Prior art date
Application number
NZ512496A
Other languages
English (en)
Inventor
Claude Singer
Judith Aronhime
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22332273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NZ512496(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NZ512496A publication Critical patent/NZ512496A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NZ512496A 1998-11-30 1999-11-30 Ethanolate of azithromycin NZ512496A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11029898P 1998-11-30 1998-11-30
PCT/US1999/028368 WO2000032203A1 (en) 1998-11-30 1999-11-30 Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
NZ512496A true NZ512496A (en) 2003-02-28

Family

ID=22332273

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ512496A NZ512496A (en) 1998-11-30 1999-11-30 Ethanolate of azithromycin

Country Status (26)

Country Link
US (1) US6365574B2 (enExample)
EP (2) EP1484062A1 (enExample)
JP (1) JP2002531409A (enExample)
KR (1) KR100603226B1 (enExample)
CN (2) CN100339384C (enExample)
AP (1) AP1709A (enExample)
AT (1) ATE279200T1 (enExample)
AU (1) AU768219B2 (enExample)
BG (1) BG105547A (enExample)
CA (1) CA2352562A1 (enExample)
CZ (1) CZ20011886A3 (enExample)
DE (1) DE69921192T2 (enExample)
DK (1) DK1152765T3 (enExample)
ES (1) ES2229804T3 (enExample)
HK (1) HK1043725B (enExample)
HU (1) HUP0104241A3 (enExample)
IL (1) IL143376A0 (enExample)
LV (1) LV12735B (enExample)
NZ (1) NZ512496A (enExample)
PL (1) PL197894B1 (enExample)
PT (1) PT1152765E (enExample)
RO (1) RO121408B1 (enExample)
RU (1) RU2240124C2 (enExample)
SI (1) SI20639A (enExample)
WO (1) WO2000032203A1 (enExample)
ZA (1) ZA200104312B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
US6245903B1 (en) 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
HU229488B1 (hu) * 2000-11-27 2014-01-28 Sandoz Ag Eljárás makrolid hidrátok elõállítására
UA76967C2 (uk) * 2000-11-27 2006-10-16 Сандоз Аг Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання
KR100431431B1 (ko) * 2001-04-25 2004-05-14 한미약품 주식회사 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
DE60209704T2 (de) * 2001-05-22 2006-11-16 Pfizer Products Inc., Groton Neue kristallforme von azithromycin
EP1652851A1 (en) 2001-05-22 2006-05-03 Pfizer Products Inc. New crystal form of Azithromycin
WO2003032922A2 (en) * 2001-10-18 2003-04-24 Teva Pharmaceutical Industries Ltd. Stabilized azithromycin compositions
EP1541134A3 (en) * 2001-10-18 2007-06-06 Teva Pharmaceutical Industries Limited Stabilized azithromycin compositions
US20080149521A9 (en) * 2001-10-18 2008-06-26 Michael Pesachovich Methods of stabilizing azithromycin
NZ532707A (en) * 2001-12-21 2006-07-28 Pfizer Prod Inc Directly compressible formulations of azithromycin
NZ532063A (en) * 2001-12-21 2006-03-31 Pfizer Prod Inc Methods for wet granulating azithromycin
MXPA04007427A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formulaciones de azitromicina granuladas por via seca.
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
JP2007513147A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押し出し機を使用して、好ましくはポロキサマーとグリセリドを含有する多粒子結晶性医薬組成物を製造するための噴霧凝結方法
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
BRPI0417338A (pt) * 2003-12-04 2007-04-17 Pfizer Prod Inc formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
RU2331410C2 (ru) * 2003-12-04 2008-08-20 Пфайзер Продактс Инк. Способ получения фармацевтических мультичастиц
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7683162B2 (en) * 2004-08-30 2010-03-23 Taro Pharmaceutical Industries Limited Process of preparing a crystalline azithromycin monohydrate
CA2591744A1 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US20060198895A1 (en) * 2005-03-07 2006-09-07 Kotliar Eleonora M Azithromycin powder for oral suspension compositions
US20090318375A1 (en) * 2005-06-08 2009-12-24 Hanmi Pharm Co., Ltd Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same
CN102413826A (zh) 2009-03-13 2012-04-11 达·沃尔泰拉公司 用于消除革兰氏阴性菌的组合物和方法
EP3366326A1 (en) * 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
CN103983730B (zh) * 2014-06-11 2015-09-30 北京市药品检验所 阿奇霉素或其制剂中的杂质检查方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU43006B (en) 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
CN1093370A (zh) * 1993-12-10 1994-10-12 北京市集才药物研究所 一种新的阿齐红霉素结晶及其制备方法
CN1161971A (zh) * 1997-01-03 1997-10-15 石家庄制药集团有限公司 一种阿齐霉素结晶及其制备方法
US6245903B1 (en) * 1998-08-21 2001-06-12 Apotex, Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
US6365574B2 (en) * 1998-11-30 2002-04-02 Teva Pharmaceutical Industries Ltd. Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
KR100491183B1 (ko) * 2001-03-21 2005-05-25 한미약품 주식회사 아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
DE60209704T2 (de) * 2001-05-22 2006-11-16 Pfizer Products Inc., Groton Neue kristallforme von azithromycin

Also Published As

Publication number Publication date
ZA200104312B (en) 2001-11-28
JP2002531409A (ja) 2002-09-24
CA2352562A1 (en) 2000-06-08
ATE279200T1 (de) 2004-10-15
HK1043725B (en) 2005-05-06
LV12735B (en) 2002-03-20
SI20639A (sl) 2002-02-28
AU3106500A (en) 2000-06-19
KR20010099806A (ko) 2001-11-09
EP1152765A1 (en) 2001-11-14
DK1152765T3 (da) 2005-01-31
PL197894B1 (pl) 2008-05-30
HK1043725A1 (en) 2002-09-27
AU768219B2 (en) 2003-12-04
BG105547A (en) 2001-12-31
HUP0104241A2 (hu) 2002-03-28
CN1273142C (zh) 2006-09-06
US20020007049A1 (en) 2002-01-17
AP2001002183A0 (en) 2001-06-30
EP1152765A4 (en) 2002-07-17
WO2000032203A1 (en) 2000-06-08
CN1737008A (zh) 2006-02-22
DE69921192T2 (de) 2006-02-16
CZ20011886A3 (cs) 2001-10-17
ES2229804T3 (es) 2005-04-16
IL143376A0 (en) 2002-04-21
LV12735A (en) 2001-10-20
RU2240124C2 (ru) 2004-11-20
PL347971A1 (en) 2002-05-06
PT1152765E (pt) 2004-12-31
HUP0104241A3 (en) 2003-12-29
KR100603226B1 (ko) 2006-08-28
DE69921192D1 (de) 2004-11-18
US6365574B2 (en) 2002-04-02
EP1484062A1 (en) 2004-12-08
AP1709A (en) 2007-02-27
CN100339384C (zh) 2007-09-26
EP1152765B1 (en) 2004-10-13
RO121408B1 (ro) 2007-05-30
CN1334735A (zh) 2002-02-06

Similar Documents

Publication Publication Date Title
AU4707899A (en) Alteration of hemicellulose concentration in plants by rgp
DE69112917D1 (de) Kristallisationsverfahren zur Verbesserung der Kristallstruktur und -grösse.
IL141664A0 (en) Biodegradable composition comprising starch and polysaccharide esters
CA2116066A1 (en) Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays
EP0917873A4 (en) EYE DROP
ZA943258B (en) Combined action of endoglucanases and cellobiohydrolases.
AU3369299A (en) Stable concentrated rare earth carboxylate liquids
IL140826A0 (en) Crystal modification of lipoic acid
CA2133885A1 (en) Crystalline inclusion complex of diclofenac with beta-cyclodextrin
ID22572A (id) Proses yang disempurnakan untuk pembuatan 3,5,5-trimetilsikloheksa-3-en-1-on (betha-isoforon) dengan isomerisasi 3,5,5-trimetilsikloheksa-2-en-1-on (alpha-isoforon) (ii)
AP9600810A0 (en) Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation.
AU4463101A (en) Process for producing aglycon by using diglycosidase and flavor-improved food containing the aglycon and converting agent to be used in the process
ITTO920791A0 (it) Procedimento per l'otten. di masselli reocolati, in particolare adattia venire utilizzati per la produzione di pressocolati ad altre presta-zioni meccaniche.
BG102076A (en) Amorphous coloured plate of crystalizing thermoplast
MX9700077A (es) Composiciones blanqueadoras de hipoclorito.
AU2002223766A1 (en) Single crystals, method for making single crystals by growth in solution and uses
WO2001042250A3 (en) Process for production of diphenyl-dialkoxysilane, phenylalkyl-dialkoxysilane, octaphenylcyclotetrasiloxane and sym-tetraalkyltetraphenyl-cyclotetrasiloxane
AR006586A1 (es) Aspartame en un soporte
PL353017A1 (en) Device for cutting two or more rods or strips arranged one after the other
KR930012914A (ko) 폴리아크릴로니트릴 한외 여과막의 제조방법
EP1555262A4 (en) METHOD OF CRYSTAL EXPOSURE
Vogelsang Investigations on corrosion inhibitors and chelating agents in alkaline solution using cyclovoltammetry
MX9605245A (es) Empleo de soluciones acuosas de sales de l-triptofano y l-treonina o ambas.
PL312966A1 (en) Derivatives of thiocarbamoil
MX9701948A (es) Epimeros de (22rs-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-e n-17beta-carboxamida.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)